Perspectives of cancer patients and their health during the COVID-19 pandemic

The immunosuppressive nature of some cancers and many cancer-directed treatments may increase the risk of infection with and severe sequelae from Coronavirus Disease 2019 (COVID-19). The objective of this study was to compare concerns about COVID-19 among individuals undergoing cancer treatment to t...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2020-10, Vol.15 (10), p.e0241741-e0241741
Main Authors: Lou, Emil, Teoh, Deanna, Brown, Katherine, Blaes, Anne, Holtan, Shernan G, Jewett, Patricia, Parsons, Helen, Mburu, E Waruiru, Thomaier, Lauren, Hui, Jane Yuet Ching, Nelson, Heather H, Vogel, Rachel I
Format: Article
Language:English
Subjects:
Adult
Anxieties
Anxiety
Breast cancer
Cancer
Cancer patients
Cancer therapies
Care and treatment
Chemotherapy
Complications
Coronaviruses
COVID-19
COVID-19 - epidemiology
COVID-19 - psychology
COVID-19 - virology
Cross-Sectional Studies
Epidemics
Female
Health risks
Humans
Infections
Logistics
Male
Medical diagnosis
Metastases
Neoplasms - epidemiology
Neoplasms - psychology
Pandemics
Privacy
Public Health
SARS-CoV-2 - isolation & purification
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Social aspects
Surveys
Surveys and Questionnaires
United States
United States - epidemiology
Viral diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The immunosuppressive nature of some cancers and many cancer-directed treatments may increase the risk of infection with and severe sequelae from Coronavirus Disease 2019 (COVID-19). The objective of this study was to compare concerns about COVID-19 among individuals undergoing cancer treatment to those with a history of cancer not currently receiving therapy and to those without a cancer history. We conducted a cross-sectional anonymous online survey study of adults currently residing in the United States. Participants were recruited over a one-week period (April 3-11, 2020) using promoted advertisements on Facebook and Twitter. Groups were compared using chi-squared tests, Fisher's exact tests, and t-tests. 543 respondents from 47 states provided information on their cancer history and were included in analyses. Participants receiving active treatment reported greater concern about infection from the SARS-CoV-2 coronavirus (p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0241741